Cumberland Pharmaceuticals Inc. Accrued Liabilities, Current
Cumberland Pharmaceuticals Inc. (CPIX) had Accrued Liabilities, Current of $7.52 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Accrued Liabilities, Current $7.52M.
- 2025-12-31: Accrued Liabilities, Current $7.77M; Accrued Liabilities, Current as first filed $12.64M.
- 2024-12-31: Accrued Liabilities, Current $12.25M.
- 2023-12-31: Accrued Liabilities, Current $13.60M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $7.52M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $7.77M 10-Q · filed 2026-08-07 | $12.64M 10-K · filed 2026-03-09 |
| 2024-12-31 | $12.25M 10-K · filed 2026-03-09 | |
| 2023-12-31 | $13.60M 10-K · filed 2025-03-07 | |
| 2022-12-31 | $17.59M 10-K · filed 2024-03-13 | |
| 2021-12-31 | $8.67M 10-K · filed 2023-03-13 | |
| 2020-12-31 | $11.25M 10-K · filed 2022-03-11 | |
| 2019-12-31 | $11.08M 10-K · filed 2021-03-12 | $11.32M 10-K · filed 2020-03-20 |
| 2018-12-31 | $16.04M 8-K · filed 2020-12-10 | $16.71M 10-K · filed 2019-03-12 |
| 2017-12-31 | $8.71M 10-K · filed 2019-03-12 | |
| 2016-12-31 | $6.76M 10-K · filed 2018-03-09 | |
| 2015-12-31 | $9.53M 10-K · filed 2017-03-13 | |
| 2014-12-31 | $10.51M 10-K · filed 2016-03-14 | |
| 2013-12-31 | $5.51M 10-K · filed 2015-03-09 | |
| 2012-12-31 | $5.26M 10-K · filed 2014-03-11 | |
| 2011-12-31 | $5.09M 10-K · filed 2013-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |